Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad Spellberg

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
Plos Pathogens|February 2, 2021
Capsule carbohydrate structure determines virulence in Acinetobacter baumanniiYuli Talyansky, Travis B Nielsen, Jun Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2011
Combating antimicrobial resistance: policy recommendations to save lives, Brad Spellberg, Martin Blaser, et al.
Mbio|August 24, 2017
Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGETravis B Nielsen, Paul Pantapalangkoor, Jun Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2023
Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort StudySarah Freling, Noah Wald-Dickler, Josh Banerjee, et al.
Nature Microbiology|June 10, 2020
A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumanniiBrian Luna, Vincent Trebosc, Bosul Lee, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2024
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection modelsYuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, et al.
The Journal of Infectious Diseases|September 22, 2017
Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading SepsisTravis B Nielsen, Paul Pantapalangkoor, Brian M Luna, et al.
Mbio|October 4, 2012
Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosisLin Lin, Brandon Tan, Paul Pantapalangkoor, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2025
Restoring cefepime activity against multidrug-resistant KPC-producing <i>Klebsiella pneumoniae</i> by combination with boronic acid inhibitors, MB076 and S02030Laura J Rojas, Travis B Nielsen, Paul Pantapalangkoor, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 14, 2026
Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach?M Gabriela Cabanilla, Bassam Ghanem, Boris Jegorović, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
Plos Pathogens|February 2, 2021
Capsule carbohydrate structure determines virulence in Acinetobacter baumanniiYuli Talyansky, Travis B Nielsen, Jun Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2011
Combating antimicrobial resistance: policy recommendations to save lives, Brad Spellberg, Martin Blaser, et al.
Mbio|August 24, 2017
Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGETravis B Nielsen, Paul Pantapalangkoor, Jun Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2023
Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort StudySarah Freling, Noah Wald-Dickler, Josh Banerjee, et al.
Nature Microbiology|June 10, 2020
A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumanniiBrian Luna, Vincent Trebosc, Bosul Lee, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2024
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection modelsYuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, et al.
The Journal of Infectious Diseases|September 22, 2017
Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading SepsisTravis B Nielsen, Paul Pantapalangkoor, Brian M Luna, et al.
Mbio|October 4, 2012
Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosisLin Lin, Brandon Tan, Paul Pantapalangkoor, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2025
Restoring cefepime activity against multidrug-resistant KPC-producing <i>Klebsiella pneumoniae</i> by combination with boronic acid inhibitors, MB076 and S02030Laura J Rojas, Travis B Nielsen, Paul Pantapalangkoor, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 14, 2026
Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach?M Gabriela Cabanilla, Bassam Ghanem, Boris Jegorović, et al.
Pageof 27